Alimera sciences announces third quarter 2022 financial results

Atlanta, nov. 14, 2022 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (“alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, today announced financial results for the third quarter of 2022. alimera will host a conference call today at 9:00 a.m. est to discuss these results.
ALIM Ratings Summary
ALIM Quant Ranking